(Q28236135)

Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.

21 January 2018

1 reference

Identification of a RING protein that can interact in vivo with the BRCA1 gene product

21 January 2018

1 reference

BRCA1 RING domain cancer-predisposing mutations. Structural consequences and effects on protein-protein interactions

21 January 2018

1 reference

Mapping the functional domains of BRCA1. Interaction of the ring finger domains of BRCA1 and BARD1

21 January 2018

1 reference

Functional communication between endogenous BRCA1 and its partner, BARD1, during Xenopus laevis development

21 January 2018

1 reference

BRCT Repeats As Phosphopeptide-Binding Modules Involved in Protein Targeting

21 January 2018

1 reference

Interactions between BRCT repeats and phosphoproteins: tangled up in two

21 January 2018

1 reference

BRCA1/BARD1 orthologs required for DNA repair in Caenorhabditis elegans

21 January 2018

1 reference

Characterization of Arabidopsis thaliana ortholog of the human breast cancer susceptibility gene 1: AtBRCA1, strongly induced by gamma rays

21 January 2018

1 reference

Mutations in the BRCA1-associated RING domain (BARD1) gene in primary breast, ovarian and uterine cancers

21 January 2018

1 reference

Mutation screening of the BARD1 gene: evidence for involvement of the Cys557Ser allele in hereditary susceptibility to breast cancer

21 January 2018

1 reference

Mutational analysis of BARD1 in familial breast cancer patients in Japan

21 January 2018

1 reference

Aberrant expression of BARD1 in breast and ovarian cancers with poor prognosis.

21 January 2018

1 reference

Loss of Bard1, the heterodimeric partner of the Brca1 tumor suppressor, results in early embryonic lethality and chromosomal instability

21 January 2018

1 reference

BARD1 induces apoptosis by catalysing phosphorylation of p53 by DNA-damage response kinase

21 January 2018

1 reference

A truncated splice variant of human BARD1 that lacks the RING finger and ankyrin repeats

21 January 2018

1 reference

Prediction of central nervous system embryonal tumour outcome based on gene expression

21 January 2018

1 reference

The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation

21 January 2018

1 reference

Targeted substrate degradation by an engineered double RING ubiquitin ligase

21 January 2018

1 reference

BRCA1 : BARD1 induces the formation of conjugated ubiquitin structures, dependent on K6 of ubiquitin, in cells during DNA replication and repair

21 January 2018

1 reference

The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity

21 January 2018

1 reference

Cancer-predisposing mutations within the RING domain of BRCA1: loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity

21 January 2018

1 reference

BARD1 induces BRCA1 intranuclear foci formation by increasing RING-dependent BRCA1 nuclear import and inhibiting BRCA1 nuclear export

21 January 2018

1 reference

The BRCA1/BARD1 heterodimer assembles polyubiquitin chains through an unconventional linkage involving lysine residue K6 of ubiquitin

21 January 2018

1 reference

Autoubiquitination of the BRCA1*BARD1 RING ubiquitin ligase

21 January 2018

1 reference

Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains

21 January 2018

1 reference

BRCA1 is associated with the centrosome during mitosis.

21 January 2018

1 reference

Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells

21 January 2018

1 reference

BRCA1-dependent ubiquitination of gamma-tubulin regulates centrosome number

21 January 2018

1 reference

BRCA1 phosphorylation by Aurora-A in the regulation of G2 to M transition

21 January 2018

1 reference

Nucleophosmin/B23 is a candidate substrate for the BRCA1-BARD1 ubiquitin ligase

21 January 2018

1 reference

Role of nucleophosmin in embryonic development and tumorigenesis

21 January 2018

1 reference

Stable X chromosome inactivation involves the PRC1 Polycomb complex and requires histone MACROH2A1 and the CULLIN3/SPOP ubiquitin E3 ligase

21 January 2018

1 reference

Evidence for a transcriptional activation function of BRCA1 C-terminal region

21 January 2018

1 reference

Common BRCA1 variants and transcriptional activation.

21 January 2018

1 reference

BRCA1 is a component of the RNA polymerase II holoenzyme

21 January 2018

1 reference

BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A

21 January 2018

1 reference

Direct DNA binding by Brca1

21 January 2018

1 reference

BRCA1/BARD1 inhibition of mRNA 3' processing involves targeted degradation of RNA polymerase II.

21 January 2018

1 reference

BRCA1/BARD1 ubiquitinate phosphorylated RNA polymerase II.

21 January 2018

1 reference

Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage

21 January 2018

1 reference

Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells

21 January 2018

1 reference

Homologous repair of DNA damage and tumorigenesis: the BRCA connection

21 January 2018

1 reference

Adenosine nucleotide modulates the physical interaction between hMSH2 and BRCA1

21 January 2018

1 reference

RNA recognition by the human polyadenylation factor CstF

21 January 2018

1 reference

Functional interaction of BRCA1-associated BARD1 with polyadenylation factor CstF-50

21 January 2018

1 reference

Mechanism and regulation of mRNA polyadenylation

21 January 2018

1 reference

Deregulation of poly(A) polymerase interferes with cell growth

21 January 2018

1 reference

The BARD1-CstF-50 interaction links mRNA 3' end formation to DNA damage and tumor suppression

21 January 2018

1 reference

Conservation of function and primary structure in the BRCA1-associated RING domain (BARD1) protein

21 January 2018

1 reference

In vitro repression of Brca1-associated RING domain gene, Bard1, induces phenotypic changes in mammary epithelial cells

21 January 2018

1 reference

BARD1 expression during spermatogenesis is associated with apoptosis and hormonally regulated

21 January 2018

1 reference

Identification of BARD1 as mediator between proapoptotic stress and p53-dependent apoptosis

21 January 2018

1 reference

p53 Phosphorylation: biochemical and functional consequences

21 January 2018

1 reference

BRCA1-BARD1 complexes are required for p53Ser-15 phosphorylation and a G1/S arrest following ionizing radiation-induced DNA damage

21 January 2018

1 reference

Nuclear-cytoplasmic translocation of BARD1 is linked to its apoptotic activity

21 January 2018

1 reference

Nuclear-cytoplasmic shuttling of BARD1 contributes to its proapoptotic activity and is regulated by dimerization with BRCA1

21 January 2018

1 reference

Antisense inhibition of BRCA1 expression and molecular analysis of hereditary tumors indicate that functional inactivation of the p53 DNA damage response pathway is required for BRCA-associated tumorigenesis

21 January 2018

1 reference

Nuclear targeting and cell cycle regulatory function of human BARD1

21 January 2018

1 reference

BARD1 regulates BRCA1 apoptotic function by a mechanism involving nuclear retention

21 January 2018

1 reference

The NF-kappa B and I kappa B proteins: new discoveries and insights

21 January 2018

1 reference

Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.

21 January 2018

1 reference

The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators

21 January 2018

1 reference

BRCA1 Augments Transcription by the NF-κB Transcription Factor by Binding to the Rel Domain of the p65/RelA Subunit

21 January 2018

1 reference

Possible causes of chromosome instability: comparison of chromosomal abnormalities in cancer cell lines with mutations in BRCA1, BRCA2, CHK2 and BUB1.

21 January 2018

1 reference

Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2

21 January 2018

1 reference

Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells

21 January 2018

1 reference

Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains

21 January 2018

1 reference

Ubiquitination and proteasomal degradation of the BRCA1 tumor suppressor is regulated during cell cycle progression.

21 January 2018

1 reference

E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints

21 January 2018

1 reference

Hyperphosphorylation of the BARD1 tumor suppressor in mitotic cells

21 January 2018

1 reference

The BRCA1 suppressor hypothesis: An explanation for the tissue-specific tumor development in BRCA1 patients

21 January 2018

1 reference

Nucleophosmin/B23, a multifunctional protein that can regulate apoptosis

21 January 2018

1 reference

Imprinted X inactivation and reprogramming in the preimplantation mouse embryo.

21 January 2018

1 reference

Stem cells and cancer; the polycomb connection

21 January 2018

1 reference

Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells

21 January 2018

1 reference

Association of BRCA1 with the inactive X chromosome and XIST RNA

21 January 2018

1 reference

The BRCA2 is a histone acetyltransferase

21 January 2018

1 reference

Gene repression by Polycomb group protein complexes: a distinct complex for every occasion?

21 January 2018

1 reference

Transcriptional activation by BRCA1

21 January 2018

1 reference

Germline mutations of the BRCA1-associated ring domain (BARD1) gene in breast and breast/ovarian families negative for BRCA1 and BRCA2 alterations

21 January 2018

1 reference

Activation of transcription in vitro by the BRCA1 carboxyl-terminal domain

31 March 2020

1 reference